表紙
市場調查報告書
商品編碼
1044099

生技藥品治療(到2026年)

Therapeutic Biologics to 2026

出版日期: | 出版商: Greystone Research Associates | 英文 120 Pages | 商品交期: 最快1-2個工作天內

價格
  • 全貌
  • 簡介
  • 目錄
簡介

醫藥品開發商,為了支援增加的慢性疾病的患者數,今後5年將加速從單回使用和複數回使用的管瓶改變為預填充式注射器供給形態。還有由於抗體,荷爾蒙,其他生物製藥的強力的生理作用,安全性和遵守的必要性高漲。

本報告提供全球生技藥品治療市場相關調查,市場要素,產品開發策略,醫藥品分類的市場分析,市場資料與預測等相關的系統性資訊。

目錄

  • 生物製藥的產品要素
    • 供給時的包裝
    • 製劑要素
    • 生物製藥的輸送生態系統
    • 技術要素
  • 競爭情形
  • 全球生技藥品供給生態系統
    • 北美
    • 歐洲
    • 亞洲
  • 生技藥品治療 - 患者處方市場區隔
    • 診療的現場
    • 自我給藥
  • 主要的生技藥品供應商的市場上的存在感
  • 醫藥品分類的市場分析
    • 酵素
    • 融合蛋白質
    • 顆粒球 - 細胞聚落刺激因子 (G-CSF)
    • 荷爾蒙
    • 免疫調節劑
    • 單株抗體(mAbs)
    • 重組蛋白質
  • 生物製藥簡介
  • 市場資料與預測
  • 生物製藥的輸送設備和供應商
目錄
Product Code: TBJ296F

Engineered Therapeutics for Refractory Conditions

Led by the proliferation of antibody-based drugs and candidates, biological drugs as a class continue to outpace all other NCEs in development pipelines and clinical trials. This shift away from small molecule drugs is creating opportunities for drug developers, device designers, packagers and - ultimately - pharmaceutical marketers. Because biological drugs most often target chronic conditions, dosing strategies and treatment protocols must be developed for long-term use, often for self-administration by patients who may have limitations directly related to their condition. The shift in as-supplied packaging from single and multi-use vials to prefilled injection devices will accelerate over the next five years as drug developers move to empower an increasing number of chronically ill patients. The powerful physiological effects of antibodies, hormones and other biological drugs also increase the need for safety and compliance.

What You Will Learn:

  • What are the market factors that define the therapeutic biologicals market?
  • What are the major factors driving product development strategies within biologicals drug development organizations?
  • How does the availability of patient support resources influence prescribing decisions for biological drugs?
  • How important are drug developer-formulation technologist relationships in therapeutic market segments?
  • What is the current state of the global biologicals development and manufacturing ecosystem?
  • What are the significant economic, technology, and regulatory factors affecting the selection criteria for therapeutic biological drugs?

Table of Contents

  • Biological Drug Product Factors
    • As-supplied Packaging
    • Formulation Factors
    • Biological Drug Delivery Ecosystem
    • Technology Factors
  • Competitive Landscape
  • Global Biologics Supply Ecosystem
    • North America
    • Europe
    • Asia
  • Therapeutic Biologicals - Patient Prescribing Segments
    • Point of Care
    • Self-administration
  • Market Presence of Leading Biologicals Suppliers
  • Drug Class Market Analysis
    • Enzymes
    • Fusion Proteins
    • Granulocyte - Colony Stimulating Factor (G-CSF)
    • Hormones
    • Immune Modulators
    • mAbs
    • Recombinant Proteins
  • Biological Drug Profiles
  • Market Data and Forecasts
  • Delivery Devices & Suppliers for Biological Drugs